yeah it's a little disappointing to not know specifics like these, but on the flip side if you were talking to a number of parties(or just one, or none for that matter) you'd want to be holding all the cards. Negotiating deals is an art where whoever is the most informed holds the leverage. I'm totally fine for it to play out and trust that the best option on the table will be the one pursued.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren approaching key milestones in Q4 2019
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.95%
!
$13.10

Ann: Neuren approaching key milestones in Q4 2019, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.10 |
Change
0.250(1.95%) |
Mkt cap ! $1.635B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $5.007M | 381.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3 | $13.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.11 | 667 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 209 | 13.080 |
5 | 371 | 13.070 |
10 | 815 | 13.060 |
9 | 1728 | 13.050 |
7 | 1386 | 13.040 |
Price($) | Vol. | No. |
---|---|---|
13.090 | 1596 | 10 |
13.100 | 1133 | 13 |
13.110 | 2002 | 12 |
13.120 | 1649 | 11 |
13.130 | 1650 | 7 |
Last trade - 13.32pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online